Equities

SINTX Technologies Inc

SINTX Technologies Inc

Actions
  • Price (USD)0.0467
  • Today's Change0.001 / 2.86%
  • Shares traded19.86m
  • 1 Year change-96.93%
  • Beta1.3964
Data delayed at least 15 minutes, as of May 01 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SINTX Technologies, Inc. is an advanced ceramics company. The Company is focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. The Company is focusing primarily on the research, development and commercialization of medical devices manufactured with silicon nitride. The Company is manufacturing, research, and development of products comprised from advanced ceramic materials for external partners. It produces silicon nitride for use in its commercial products and product candidates in various forms: solid silicon nitride, porous silicon nitride, silicon nitride powder, composites of silicon nitride and PEEK and PEKK and silicon nitride coating. It is also focused on development and manufacturing ceramics for personnel, aircraft, and vehicle armor. Its silicon nitride products can be polished to a smooth and wear-resistant surface for articulating applications, such as bearings for hip and knee replacements.

  • Revenue in USD (TTM)2.63m
  • Net income in USD-8.29m
  • Incorporated1996
  • Employees43.00
  • Location
    SINTX Technologies Inc1885 West 2100 StreetSALT LAKE CITY 84119United StatesUSA
  • Phone+1 (801) 839-3516
  • Fax+1 (801) 839-3605
  • Websitehttps://sintx.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Escalon Medical Corp12.38m450.50k1.48m38.007.721.582.990.11980.02590.02591.180.19512.654.048.01325,898.7014.68-1.7635.71-3.6746.2644.575.54-0.91141.0931.900.1504--13.801.33760.89-17.06-19.85--
Tivic Health Systems Inc1.23m-8.26m1.52m16.00--0.2645--1.24-42.45-42.452.753.930.16131.0710.8676,687.50-108.51---135.42--26.49---672.78--5.53--0.00--46.38---18.86------
Nemaura Medical Inc0.00-10.65m1.73m36.00---------0.3787-0.37870.00-0.61690.000.00--0.00-117.49-58.18---131.96-------7,384.830.0305-1.4710.81---84.71---1.85--64.14--
Prosomnus Inc25.61m-15.02m1.74m129.00------0.0679-0.942-0.9421.52-1.331.2011.868.85198,496.50-70.44---164.95--52.38---58.65--1.38-3.152.57--37.79---19.54------
NanoVibronix Inc2.28m-3.71m2.05m10.00--0.3771--0.8964-2.15-2.151.301.950.36370.304113.96228,300.00-59.13-116.16-95.36-169.3667.3250.47-162.55-570.471.53-13.970.00--203.5948.3331.88---34.02--
Therapeutic Solutions International Inc98.99k-2.17m2.12m3.00--1.69--21.37-0.0007-0.00070.000030.00030.02871.134.4432,996.67-64.51-162.32-169.11--62.8567.79-2,247.41-2,391.850.0333-4.920.373---52.1395.3543.11------
SINTX Technologies Inc2.63m-8.29m2.32m43.00--0.0275--0.8828-2.03-2.030.70411.650.16871.345.1961,093.02-53.05-45.71-81.96-57.3670.1658.47-314.39-681.801.60--0.0052--68.2994.2449.75--54.10--
Nuwellis Inc8.86m-22.63m2.35m59.00--0.2934--0.2651-13.45-13.454.510.56510.51471.675.28150,237.30-117.35-98.07-152.04-122.4856.2255.22-227.99-230.511.96-5.060.00--3.7612.14-55.78--4.61--
Dynatronics Corp35.18m-5.70m2.49m154.00--0.3067--0.0709-1.38-1.388.393.431.093.167.84228,421.30-15.46-6.02-21.69-8.3021.5227.33-14.12-4.550.6695-19.740.1955---8.41-8.81-19.84---5.11--
VirExit Technologies Inc0.00-1.80m2.56m-----------0.0932-0.1130.00-0.03670.00-------6,103.43-----------------3.66-----100.00--19.08------
Innovative Eyewear Inc1.15m-6.66m2.64m11.00--0.4634--2.29-0.6442-0.64420.10980.43030.21134.0511.33104,770.90-122.17---137.62---10.35---578.18--8.14-2,255.110.00--74.67---17.28------
InnerScope Hearing Technologies, Inc.334.45k-7.15m2.67m24.00------8.00-0.0153-0.01530.0002-0.00280.09553.931.71---204.11-27.82---94.5317.7958.17-2,138.50-42.130.0022-0.4232------100.59----233.50--
Vycor Medical Inc1.46m-387.45k2.74m8.00------1.88-0.0122-0.01240.0432-0.10191.580.60027.86182,575.00-6.81-47.86----90.0889.60-4.32-35.420.08590.389----19.43-0.654246.49---31.77--
Invo Bioscience Inc3.02m-8.03m2.74m25.00------0.9081-9.13-9.132.570.35820.24176.7327.75120,822.80-64.30-94.63-120.25-151.4541.2074.91-266.00-343.110.1211-6.860.7558--267.3843.6226.24--87.09--
Tenon Medical Inc2.93m-15.58m2.81m21.00--2.52--0.961-10.28-10.281.620.29920.33593.487.85139,428.60-178.74---264.89--42.38---532.14--1.06--0.6012--323.73--17.63------
Data as of May 01 2024. Currency figures normalised to SINTX Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

20.34%Per cent of shares held by top holders
HolderShares% Held
L1 Capital Global, Inc.as of 25 Mar 20244.50m19.84%
The Vanguard Group, Inc.as of 31 Dec 202343.41k0.19%
Geode Capital Management LLCas of 31 Dec 202322.25k0.10%
SSgA Funds Management, Inc.as of 31 Dec 202317.29k0.08%
Virtu Americas LLCas of 31 Dec 202314.92k0.07%
Two Sigma Securities LLCas of 31 Dec 202310.14k0.05%
Morgan Stanley & Co. LLCas of 31 Dec 20232.23k0.01%
Tower Research Capital LLCas of 31 Dec 20231.41k0.01%
BlackRock Fund Advisorsas of 31 Dec 2023710.000.00%
SignatureFD LLCas of 31 Dec 2023573.000.00%
More ▼
Data from 31 Dec 2023 - 28 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.